학술논문
Enhancing the therapeutic efficacy of programmed death ligand 1 antibody for metastasized liver cancer by overcoming hepatic immunotolerance in mice.
Document Type
Article
Source
Hepatology (02709139); Sep2022, Vol. 76 Issue 3, p630-645, 16p
Subject
Language
ISSN
02709139